Polycomb Protein SCML2 Regulates the Cell Cycle by Binding and Modulating CDK/CYCLIN/p21 Complexes

PLoS Biology

Volumn 11, Issue 12, 2013, Pages

  Lecona, Emilio ^a,b   Rojas, Luis Alejandro ^a   Bonasio, Roberto ^a,c   Johnston, Andrew ^a   Fernández Capetillo, Oscar ^b   Reinberg, Danny ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; POLYCOMB GROUP PROTEIN; POLYCOMB GROUP PROTEIN SCML2B; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ASSAY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; S PHASE CELL CYCLE CHECKPOINT; UPREGULATION;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; G1 PHASE; HELA CELLS; HUMANS; PHOSPHORYLATION; POLYCOMB-GROUP PROTEINS;

EID: 84892760092     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001737     Document Type: Article

References (71)

1. Simon JA, Kingston RE, (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10: 697-708.
2. Schwartz YB, Pirrotta V, (2007) Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8: 9-22.
3. Scheuermann JC, de Ayala Alonso AG, Oktaba K, Ly-Hartig N, McGinty RK, et al. (2010) Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465: 243-247.
4. Lagarou A, Mohd-Sarip A, Moshkin YM, Chalkley GE, Bezstarosti K, et al. (2008) dKDM2 couples histone H2A ubiquitylation to histone H3 demethylation during Polycomb group silencing. Genes Dev 22: 2799-2810.
5. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039-1043.
6. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D, (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 16: 2893-2905.
7. Francis NJ, Saurin AJ, Shao Z, Kingston RE, (2001) Reconstitution of a functional core polycomb repressive complex. Mol Cell 8: 545-556.
8. Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, et al. (2004) Role of histone H2A ubiquitination in Polycomb silencing. Nature 431: 873-878.
9. Wang L, Jahren N, Miller EL, Ketel CS, Mallin DR, et al. (2010) Comparative analysis of chromatin binding by Sex Comb on Midleg (SCM) and other polycomb group repressors at a Drosophila Hox gene. Mol Cell Biol 30: 2584-2593.
10. Grimm C, Matos R, Ly-Hartig N, Steuerwald U, Lindner D, et al. (2009) Molecular recognition of histone lysine methylation by the Polycomb group repressor dSfmbt. EMBO J 28: 1965-1977.
11. Sathyamurthy A, Allen MD, Murzin AG, Bycroft M, (2003) Crystal structure of the malignant brain tumor (MBT) repeats in Sex Comb on Midleg-like 2 (SCML2). J Biol Chem 278: 46968-46973.
12. Bornemann D, Miller E, Simon J, (1996) The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein. Development 122: 1621-1630.
13. Shao Z, Raible F, Mollaaghababa R, Guyon JR, Wu CT, et al. (1999) Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell 98: 37-46.
14. Peterson AJ, Kyba M, Bornemann D, Morgan K, Brock HW, et al. (1997) A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions. Mol Cell Biol 17: 6683-6692.
15. Grimm C, de Ayala Alonso AG, Rybin V, Steuerwald U, Ly-Hartig N, et al. (2007) Structural and functional analyses of methyl-lysine binding by the malignant brain tumour repeat protein Sex comb on midleg. EMBO Rep 8: 1031-1037.
16. Peterson AJ, Mallin DR, Francis NJ, Ketel CS, Stamm J, et al. (2004) Requirement for sex comb on midleg protein interactions in Drosophila polycomb group repression. Genetics 167: 1225-1239.
17. Trojer P, Reinberg D, (2008) Beyond histone methyl-lysine binding: how malignant brain tumor (MBT) protein L3MBTL1 impacts chromatin structure. Cell Cycle 7: 578-585.
18. Bonasio R, Lecona E, Reinberg D, (2010) MBT domain proteins in development and disease. Semin Cell Dev Biol 21: 221-230.
19. van de Vosse E, Walpole SM, Nicolaou A, van der Bent P, Cahn A, et al. (1998) Characterization of SCML1, a new gene in Xp22, with homology to developmental polycomb genes. Genomics 49: 96-102.
20. Berger J, Kurahashi H, Takihara Y, Shimada K, Brock HW, et al. (1999) The human homolog of Sex comb on midleg (SCMH1) maps to chromosome 1p34. Gene 237: 185-191.
21. Montini E, Buchner G, Spalluto C, Andolfi G, Caruso A, et al. (1999) Identification of SCML2, a second human gene homologous to the Drosophila sex comb on midleg (Scm): a new gene cluster on Xp22. Genomics 58: 65-72.
22. Tomotsune D, Takihara Y, Berger J, Duhl D, Joo S, et al. (1999) A novel member of murine Polycomb-group proteins, Sex comb on midleg homolog protein, is highly conserved, and interacts with RAE28/mph1 in vitro. Differentiation 65: 229-239.
23. Levine SS, Weiss A, Erdjument-Bromage H, Shao Z, Tempst P, et al. (2002) The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans. Mol Cell Biol 22: 6070-6078.
24. Takada Y, Isono K, Shinga J, Turner JM, Kitamura H, et al. (2007) Mammalian Polycomb Scmh1 mediates exclusion of Polycomb complexes from the XY body in the pachytene spermatocytes. Development 134: 579-590.
25. Luo L, Yang X, Takihara Y, Knoetgen H, Kessel M, (2004) The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature 427: 749-753.
26. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, et al. (2009) Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41: 465-472.
27. Vissers JH, van Lohuizen M, Citterio E, (2012) The emerging role of Polycomb repressors in the response to DNA damage. J Cell Sci 125: 3939-3948.
28. Popov N, Gil J, (2010) Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics 5: 685-690.
29. Lu Z, Hunter T, (2010) Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell Cycle 9 (12):: 2342-2352.
30. Su WJ, Fang JS, Cheng F, Liu C, Zhou F, et al. (2013) RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development. Proc Natl Acad Sci U S A 110: 1720-1725.
31. Wen W, Peng C, Kim MO, Ho Jeong C, Zhu F, et al. (2013) Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability. Oncogene.
32. Mohd-Sarip A, Lagarou A, Doyen CM, van der Knaap JA, Aslan U, et al. (2012) Transcription-independent function of Polycomb Group Protein PSC in cell cycle control. Science 336 (6082):: 744-747.
33. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, et al. (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400.
34. Hengst L, Gopfert U, Lashuel HA, Reed SI, (1998) Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1). Genes Dev 12: 3882-3888.
35. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP, (1996) Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382: 325-331.
36. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105: 10762-10767.
37. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3: ra3.
38. Gnad F, Ren S, Cox J, Olsen JV, Macek B, et al. (2007) PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol 8: R250.
39. Liou YC, Zhou XZ, Lu KP, (2011) Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci 36: 501-514.
40. Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, et al. (2012) Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell Death Differ 19: 1152-1161.
41. Resnitzky D, Gossen M, Bujard H, Reed SI, (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669-1679.
42. Ohtsubo M, Roberts JM, (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912.
43. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, et al. (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci U S A 91: 8655-8659.
44. Li R, Waga S, Hannon GJ, Beach D, Stillman B, (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537.
45. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller R, (1994) Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9: 995-997.
46. Oda H, Hubner MR, Beck DB, Vermeulen M, Hurwitz J, et al. (2010) Regulation of the histone H4 monomethylase PR-Set7 by CRL4(Cdt2)-mediated PCNA-dependent degradation during DNA damage. Mol Cell 40: 364-376.
47. Maimets T, Neganova I, Armstrong L, Lako M, (2008) Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 27: 5277-5287.
48. Spivakov M, Fisher AG, (2007) Epigenetic signatures of stem-cell identity. Nat Rev Genet 8: 263-271.
49. Sparmann A, van Lohuizen M, (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846-856.
50. Martinez AM, Cavalli G, (2006) The role of polycomb group proteins in cell cycle regulation during development. Cell Cycle 5: 1189-1197.
51. Martinez AM, Colomb S, Dejardin J, Bantignies F, Cavalli G, (2006) Polycomb group-dependent Cyclin A repression in Drosophila. Genes Dev 20: 501-513.
52. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M, (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168.
53. Dietrich N, Bracken AP, Trinh E, Schjerling CK, Koseki H, et al. (2007) Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J 26: 1637-1648.
54. Maertens GN, El Messaoudi-Aubert S, Racek T, Stock JK, Nicholls J, et al. (2009) Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. PLoS One 4: e6380 doi:10.1371/journal.pone.0006380.
55. Forzati F, Federico A, Pallante P, Abbate A, Esposito F, et al. (2012) CBX7 is a tumor suppressor in mice and humans. J Clin Invest 122: 612-623.
56. Planas-Silva MD, Weinberg RA, (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol 17: 4059-4069.
57. Sweeney KJ, Swarbrick A, Sutherland RL, Musgrove EA, (1998) Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene 16: 2865-2878.
58. Uhlmann F, Bouchoux C, Lopez-Aviles S, (2011) A quantitative model for cyclin-dependent kinase control of the cell cycle: revisited. Philos Trans R Soc Lond B Biol Sci 366: 3572-3583.
59. Kapinas K, Grandy R, Ghule P, Medina R, Becker K, et al. (2013) The abbreviated pluripotent cell cycle. J Cell Physiol 228: 9-20.
60. Ruiz S, Panopoulos AD, Herrerias A, Bissig KD, Lutz M, et al. (2011) A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol 21: 45-52.
61. Kaneko S, Li G, Son J, Xu CF, Margueron R, et al. (2010) Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 24: 2615-2620.
62. Wei Y, Chen YH, Li LY, Lang J, Yeh SP, et al. (2011) CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 13: 87-94.
63. Wu SC, Zhang Y, (2011) Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 286: 28511-28519.
64. Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, et al. (2010) Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 12: 1108-1114.
65. Classen AK, Bunker BD, Harvey KF, Vaccari T, Bilder D, (2009) A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling. Nat Genet 41: 1150-1155.
66. Martinez AM, Schuettengruber B, Sakr S, Janic A, Gonzalez C, et al. (2009) Polyhomeotic has a tumor suppressor activity mediated by repression of Notch signaling. Nat Genet 41: 1076-1082.
67. Wang W, Yuasa T, Tsuchiya N, Ma Z, Maita S, et al. (2009) The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance. Int J Cancer 125: 2836-2843.
68. Grubach L, Juhl-Christensen C, Rethmeier A, Olesen LH, Aggerholm A, et al. (2008) Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. Eur J Haematol 81: 112-122.
69. Addou-Klouche L, Adelaide J, Finetti P, Cervera N, Ferrari A, et al. (2010) Loss, mutation and deregulation of L3MBTL4 in breast cancers. Mol Cancer 9: 213.
70. Lecona E, Barrasa JI, Olmo N, Llorente B, Turnay J, et al. (2008) Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase. Mol Cell Biol 28: 4665-4674.
71. Gao Z, Zhang J, Bonasio R, Strino F, Sawai A, et al. (2012) PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol Cell 45: 344-356.